3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
13
Sarcoma
10
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
111
Triple Negative Breast Neoplasms
25
Lung Neoplasms
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Laryngeal Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Bile Duct Neoplasms
2
Interventions
selpercatinib
2
Trastuzumab
2
Paclitaxel
2
sodium thiosulfate
1
pazopanib
1
glutathione pegylated liposomal doxorubicin
1
fluoroacetic acid
1
elacestrant
1
durvalumab
1
carboxyamido-triazole
1
abemaciclib
1
Temozolomide
1
Taxes
1
Surveys and Questionnaires
1
RAD1901
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
MLN 8237
1
Levofloxacin
1
Lapatinib
1
Immunotherapy
1
Immunoenzyme Techniques
1
Genetic Testing
1
Genetic Counseling
1
Gemcitabine
1
Drug Therapy
1
D-methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Drug Therapy
×
Breast
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled